Fig. 2From: Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong KongCumulative incidence of HCC after the initiation of DAA therapy, a stratified by the presence or absence of previous HCC before DAA therapy; b stratified by the presence or absence of cirrhosis. CRR, complete radiologic responseBack to article page